Successful aging: insights from proteome analyses of healthy centenarians by Santos-Lozano, Alejandro et al.
www.aging-us.com 3502 AGING 
www.aging-us.com AGING 2020, Vol. 12, No. 4 
Research Paper 
Successful aging: insights from proteome analyses of healthy 
centenarians 
 
Alejandro Santos-Lozano1,2,*, Pedro L. Valenzuela3,*, Francisco Llavero4, Simone Lista5,6,7, Pedro 
Carrera-Bastos8,9, Harald Hampel5, Helios Pareja-Galeano10, Beatriz G. Gálvez10, Juan Antonio 
López11,12, Jesús Vázquez11,12, Enzo Emanuele13, José L. Zugaza4,14,15,#, Alejandro Lucia2,10,16,# 
 
1Research Institute of the Hospital 12 de Octubre (“imas12”), Madrid, Spain 
2i+HeALTH, European University Miguel de Cervantes, Valladolid, Spain 
3Systems Biology Department, University of Alcalá, Madrid, Spain 
4Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain 
5Sorbonne University, GRC no. 21, Alzheimer Precision Medicine (APM), Pitié-Salpêtrière Hospital, Paris, France 
6Brain and Spine Institute (ICM), Paris, France 
7Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France 
8Centre for Primary Health Care Research, Lund University/Region Skane, Skane University Hospital, Malmo, Sweden 
9Nutriscience – Education and Consulting, Lisbon, Portugal 
10Faculty of Sport Sciences, European University of Madrid, Madrid, Spain 
11Laboratory of Cardiovascular Proteomics, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 
Madrid, Spain 
12Centro Integrado de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain 
132E Science, Robbio, Italy 
14Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, 
UPV/EHU, Leioa, Spain 
15IKERBASQUE, Basque Foundation for Science, Bilbao, Spain 




Correspondence to: Alejandro Lucia; email: alejandro.lucia@universidadeuropea.es 
Keywords: proteomics, healthy aging, elderly, senescence, immune system 
Received: November 27, 2019 Accepted: January 28, 2020  Published: February 25, 2020 
 
Copyright: Santos-Lozano et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 




Healthy aging depends on a complex gene-environment network that is ultimately reflected in the expression of 
different proteins. We aimed to perform a comparative analysis of the plasma proteome of healthy centenarians 
(n=9, 5 women, age range 100–103 years) with a notably preserved ambulatory capacity (as a paradigm of 
‘successful’ aging), and control individuals who died from a major age-related disease before the expected life 
expectancy (n=9, 5 women, age range: 67–81 years), and while having impaired ambulatory capacity (as a 
paradigm of ‘unsuccessful’ aging). We found that the expression of 49 proteins and 86 pathways differed between 
the two groups. Overall, healthy centenarians presented with distinct expression of proteins/pathways that reflect 
a healthy immune function, including a lower pro-inflammatory status (less ‘inflammaging’ and autoimmunity) and 
a preserved humoral immune response (increased B cell-mediated immune response). Compared with controls, 
healthy centenarians also presented with a higher expression of proteins involved in angiogenesis and related to  
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INTRODUCTION 
 
The aging process is characterized by progressive 
changes to the integrity of body tissues and systems [1]. 
Notably, aging is associated with chronic systemic 
inflammation (CSI, as reported in various cohorts from 
industrialized countries) [2]. CSI is not the only 
immune response altered by aging, since both innate 
and adaptive immune responses are affected [3]. The 
cardiovascular system is another important target of the 
aging process [4], which combined with CSI leads to a 
higher risk of cardiovascular disease (CVD) [2], 
representing the main cause of death in people older 
than 65 years [5]. Finally, another feature of aging is a 
change in cell barrier integrity, which is essential to 
maintain cellular homeostasis [6, 7]. 
 
Centenarians are the survival tail of the population and 
represent – especially if free of major diseases – a good 
model of healthy (or 'successful') aging since they have 
escaped diseases of the pre-antibiotic era, and have 
evaded (or at least postponed) age-related diseases and 
their fatal consequences. In this respect, blood proteome 
analysis might provide important information on causal 
mechanisms of healthy aging because it reflects both 
inherent (genetics) and environmental factors [8], and 
can help to reveal the protein networks and individual 
protein candidates involved in disease or aging 
processes [9]. However, to our knowledge no previous 
study has assessed the plasma proteome of healthy 
centenarians. 
 
It was the purpose of this study to perform a novel, 
comparative analysis of the plasma proteome of healthy 
centenarians – as a paradigm of successful aging – and 
controls from the same geographic location who died 
from a major age-related disease before the expected life 
expectancy – as a paradigm of unsuccessful aging. We 
hypothesized that a more favorable ‘aging proteome 
profile’ (e.g., at the inflammatory and cardiovascular 
level) together with differential expression of some 
specific candidate proteins, would be identified in 




The participants’ main characteristics are shown in 
Table 1. Healthy centenarians were significantly older 
(by 25 years on average) than controls but had a more 
preserved ambulatory capacity (p<0.001). 
A total of 949 human proteins were identified by liquid 
chromatography coupled to tandem mass spectrometry, 
of which 798 valid protein entries were used in the next 
steps of the study and 151 were filtered out (24 
corresponded to keratin, 17 proteins could not be traced 
to a valid reviewed human UniProt, and 110 were traced 
to the same reviewed human UniProt entry as other 




Forty-nine plasma proteins showed significantly 
differential expression between the two study groups 
(false discovery rate [FDR] q-value <0.05), of which 
17 and 32 were upregulated and downregulated, 
respectively, in healthy centenarians compared with 
controls (Supplementary Table 1). The 10 proteins that 
showed a greatest degree of differential expression 
(i.e., Log2 fold change (FC) >1.95 and false discovery 
rate [FDR] q-value <0.05) between centenarians and 
controls and were thus considered to be the best 
candidates were: C-type lectin domain family 3 
member B (CLEC3B), cysteine-rich secretory protein 
3 (CRISP3), insulin like growth factor binding protein 
(IGFALS), taste 1 receptor member 3 (TAS1R3), and 
transforming growth factor beta induced (TGFBI) – 
which were upregulated in healthy centenarians 
compared to their unhealthy controls, and thus 
potentially associated with healthy (successful) aging; 
and aminopeptidase (AOPEP), complement com-
ponent 1S (C1S), cluster of differentiation 14 (CD14), 
cyclin dependent kinase like 1 (CDKL1), and cartilage 
acidic protein 1 (CRTAC1) – which were down-
regulated in the aforementioned group and thus 
potentially associated with the opposite phenotype, 
unhealthy or unsuccessful aging. 
 
On the other hand, when analyzing male and female 
data separately, no differentially expressed proteins 
were found between healthy centenarians and controls 
using the same statistical threshold, likely due to the 
smaller number of samples analyzed.  
 
Gene set enrichment analysis 
 
The level of expression of the 798 proteins was 
successfully transformed into the signal-to-noise ratio 
ranking parameter (according to gene set enrichment 
analysis [GSEA] software) and was used in the GSEA 
enrichment analyses. A total of 86 enriched pathways 
enhanced intercellular junctions, as well as a lower expression of proteins involved in cardiovascular 
abnormalities. The identification of these proteins/pathways might provide new insights into the biological 
mechanisms underlying the paradigm of healthy aging. 
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Table 1. Clinical characteristics of healthy centenarians and controls. 




Male Alive - 101 Hearing impairment 3 
Male Alive - 100 Visual impairment 3 
Male Alive - 102 Nothing significant 2 
Male Alive - 102 Hearing impairment 3 
Female Alive - 101 Nothing significant  2 
Female Alive - 103 Visual and hearing impairment 3 
Female Alive - 101 Visual impairment 3 
Female Alive - 100 Nothing significant 3 
Female Alive - 101 Visual and hearing impairment 3 
    Mean (SD): 101 (1)  
Median (IQ): 
3 (0.5) 
       
Controls 
Male Died Stroke 67 Stroke, cognitive disturbances 2 
Male Died Aortic aneurysm rupture 79 
Peripheral artery disease, transient 
ischemic attacks 2 
Male Died Multi-organ failure 75 Frailty, cognitive decay, sarcopenia 0 
Male Died Acute myocardial infarction 81 
Cognitive decay, acute myocardial 
infarction 2 
Female Died Stroke 73 Femur fracture, syncope, stroke 1 
Female Died Stroke 72 Behavioral disturbances, memory loss, stroke 1 
Female Died Traumas after fall 74 Vertebral fractures, osteoporosis, fall 0 
Female Died Sudden cardiac death 68 
Behavioral disturbances, transient 
ischemic attacks 2 
Female Died Acute myocardial infarction 81 Frailty, acute myocardial infarction 2 
    Mean (SD): 74 (5)  
Median (IQ): 
2 (1.5) 
Abbreviations: FAC, Functional ambulatory capacity (see text for explanations); IQ, interquartile range; SD, standard 
deviation. Symbol: * p≤0.001 for the comparison between the two groups. 
 
Table 2. Number of enriched pathways identified in the global and sex-specific analysis according to the false 
discovery rate (FDR) threshold value applied. 
 Global Men Women 











Healthy centenarians 11 8 8 4 19 12 
Controls 38 28 5 4 58 37 
 
(FDR q-values <0.1) were found, of which 22 and 64 
were upregulated and downregulated, respectively, in 
healthy centenarians compared with controls (Table 2, 
see also Figure 1 for a network summary). 
 
To gain insight into the molecular mechanisms associated 
with healthy or successful aging, proteins were grouped 
into the following biological processes: (i) immune 
system-related pathways (Supplementary Table 2); (ii) 
cell junctions (Table 3); (iii) cardiovascular system 
abnormalities (angiogenesis, coagulation and CVD; 
Table 4); and (iv) other processes (Table 5: intracellular 
mechanisms [i.e., ATPase and microtubule motor 
activity, MAPK signaling pathway], metabolic 
alterations, and age-related diseases, as well as other 
conditions). Overall, centenarians presented with 
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enrichment in general immune response mechanisms, B 
cell-mediated immune responses and phagocytosis 
whereas the opposite trend was found for T cell-mediated 
immune response, complement-mediated cytolysis, and 
immune system-related pathological states such as CSI 
(also known as ‘inflammaging’ when it affects old 
people), autoimmunity, infection and other immune 
response-related diseases. The expression of proteins 
involved in cell junction integrity was also upregulated in 
healthy centenarians compared with controls, and the 
former showed a higher expression of proteins involved in 
angiogenesis and a lower expression of proteins involved 




The likelihood of healthy aging is dependent upon 
complex gene-environment interactions that are 
ultimately reflected in the control of expression of 
different proteins. In this respect, the present study 
identifies a number of proteins whose expression 
levels in plasma seem to differ between healthy 
centenarians with largely preserved ambulatory 
capacity − who can be considered a paradigm of 
healthy or successful aging − and a control group of 
individuals who had an unsuccessful aging process 
(i.e., died before the expected mean life expectancy, 
before reaching the status of ‘oldest old’ [≥85 years] 
due to an age-related disease, mainly CVD, and while 
having an impaired ambulatory capacity). The 10 
‘best’ candidate proteins, that is, those showing the 
greatest difference in expression levels between 
healthy centenarians and controls and which could 
therefore be of special interest for future replication 
studies at the individual protein level were CLEC3B, 
CRISP3, IGFALS, TAS1R3, and TGFBI (all been 
potentially associated with successful aging) and 
AOPEP, CD14, CDKL1, and CRTAC1 (unsuccessful 
aging). CELC3B (also known as tetranectin) is s 
thought to participate in plasminogen activator–related 
biological processes such as tissue degradation/ 
remodeling and extracellular proteolysis and a 
missense variant in CELC3B gene (p.S106G) has been 
recently associated with extreme longevity (reaching 
95+ years) in East Asian populations [10]. To the best 
of our knowledge, no direct/indirect evidence with 
regard to extreme longevity or successful aging has 
been reported for the rest of these candidate proteins. 
 
Figure 1. Representation of the biological relationships between healthy and unhealthy aging by subnetworks. The processes 
shared by 50 or more common proteins (i.e., those reflecting the strongest relationships) are shown. Nodes are filled in green and red 
background for proteins upregulated and downregulated, respectively, in healthy, functional centenarians compared with a control group 
with the opposite phenotype (i.e., mostly composed of people with low functional independence and who died from cardiovascular disease 
before becoming an octogenarian). 
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Table 3. Cell junction-related processes differentially expressed in healthy centenarians compared with controls. 










BEDPATH Squamous epithelial oral cell keratinized tight junction  -  0.042  0.040  Cell junctions  ↑  
BEDPATH Pneumocyte type II tight junction  -  0.047  0.035  Cell junctions  ↑  
BEDPATH Endothelial tight junctions  -  0.048  0.063  Cell junctions  ↑  
BEDPATH Lung basal cell tight junction  -  0.069  0.035  Cell junctions  ↑  
BEDPATH Squamous epithelial ectocervix basal cell tight junction  -  -  0.042  Cell junctions  ↑  
BEDPATH Tight junctions in non-keratinized epithelium  -  0.052  0.050  Cell junctions  ↑  
FDR q-values <0.5 are highlighted in bold, and those between 0.05 and 0.1 are in grey font. Symbol: ↑, higher expression in 
healthy centenarians compared with controls (also denoted by green). 
 
Table 4. Cardiovascular system-related processes differentially expressed in healthy centenarians compared with 
controls. 











GOPROCESS Angiogenesis  -  -  0.058  Angiogenesis  ↑  
BEDMOTIVE [Septic_Shock] Procoagulative Cascade  0.006  -  <0.001  Coagulation  ↓ 
GOLOCATION Extracellular exosome  0.068  -  0.023  Coagulation  ↓ 
KEGG 04610_Complement and coagulation cascades  -  -  0.059  Coagulation  ↓ 
BED Thrombophlebitis  -  -  0.059  Coagulation  ↓ 
BED Myxomatous mitral valve disease  0.008  -  0.005  CVD ↓ 
BED Myocardial infarction  -  -  0.030  CVD ↓ 
BED Stroke  -  -  0.044  CVD ↓ 
FDR q-values <0.5 are highlighted in bold, and those between 0.05 and 0.1 are in grey font. Symbols: ↑, ↓ higher and lower 
expression in healthy centenarians, respectively, compared with controls (also denoted by green and red, respectively). 
 
Previous research has attempted to identify the proteomic 
signatures of aging [11, 12] (see Supplementary Table 1 
for a comparison with our main results). Some proteins 
that were significantly downregulated in healthy 
centenarians and thus theoretically associated with 
unsuccessful aging according to our results – albumin, 
beta 2 microglobulin (B2M), complement component 9 
(C9), cystatin 3 (CST3), EGF-containing fibulin-like 
extracellular matrix protein 1 (EEMP1), lysozyme, and 
serpin peptidase inhibitor, clade G (C1 inhibitor), 
member 1 (SERPING1) − were recently shown to be 
positively correlated with chronological age in a cohort 
of healthy men and women aged 22–93 years [12]. In the 
aforementioned report, TGBI – which in our study was a 
potential biomarker of successful aging – was also 
correlated with chronological age Thus, although 
differences in study design make comparisons difficult, 
taken together the present findings and those of previous 
research with old – albeit non-centenarian – adults [11, 
12] suggest that (i) the expression levels of these proteins 
(albumin, B2M, C9, CST3, EEMP1, lysozyme, 
SERPING1, TGFBI) usually increase with age in the 
overall population, and yet (ii) an attenuation of this 
increasing trend – although maybe not for TGFBI – 
might be a signature of reaching extremely advanced 
ages in good health conditions. In turn, our findings that 
the expression levels of serpin family F member 2 
(SERPINF2, also known as alpha 2- 
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Table 5. Other processes differentially expressed between healthy centenarians and controls. 









GOFUNCTIONID ATPase activity  -  -  0.062  Intracellular mechanisms  ↑  
GOFUNCTIONID Microtubule motor activity  -  -  0.071  Intracellular mechanisms  ↑  
KEGG 04010_MAPK signaling pathway  -  -  0.070  Intracellular mechanisms  ↓ 
KEGG Response to ethanol  -  -  0.071  Metabolic alterations  ↓ 
BED Osteoarthritis  -  -  0.095  Age-related and other diseases  ↓ 
BED Non-alcoholic fatty liver disease  -  -  0.053  
Age-related and other 
diseases  ↓ 
BED Acne vulgaris  -  -  0.080  Age-related and other diseases  ↓ 
FDR q-values <0.5 are highlighted in bold, and those between 0.05 and 0.1 are in grey font. Symbols: ↑, ↓ higher and lower 
expression in healthy centenarians, respectively, compared with controls (also denoted by green and red, respectively). 
 
antiplasmin) were significantly elevated in healthy 
centenarians compared to old but non-centenarians 
controls add complementary information to the inverse 
correlation with chronological age (β=-0.026) found for 
this protein in the study by Tanaka et al [12], and might 
suggest that this protein is associated with chronological 
– but not necessarily ‘unhealthy’ – aging. SERPINF2 
acts as a major inhibitor of plasmin, which degrades 
fibrin and other proteins involved in blood clotting. 
Higher levels of α2-antiplasmin have been reported in 
healthy people compared to age-matched individuals 
with myocardial infarction [13], which could support 
the present findings of higher SERPINF2 levels in 
healthy centenarians compared to diseased controls. 
However, other authors found a positive relationship 
between α2-antiplasmin levels and the risk of 
myocardial infarction or coronary heart disease [14, 15], 
although in one of these studies the relationship was due 
to a positive association between α2-antiplasmin levels 
and other CVD risk factors (i.e., blood pressure, 
cholesterol levels) [15]. Thus, further research in larger 
and more varied cohorts and including replication 
analyses is needed to clarify the influence of SERPINF2 
on both aging and cardiovascular health.  
 
The observed proteomic changes overall reflect that 
healthy centenarians present with a higher expression of 
proteins involved in angiogenesis and cell junction 
integrity, but with a reduction in those involved in the 
incidence of CVD. Regarding cell junctions, we found 
that healthy centenarians showed a higher expression of 
proteins related to enhanced paracellular barrier 
function. This is relevant because intercellular inter-
actions play a major role in establishing the architecture 
of tissues and organs, and consequently in the 
regulation of cell proliferation and migration, as well as 
in maintaining tissue barrier homeostasis and function 
in different organs [6]. Indeed, disruption of cell 
junctions is associated with numerous conditions such 
as neuronal dysfunction and neurodegeneration [16], 
sarcopenia (muscle atrophy) [17], cardio-myopathies 
[18], CSI [19], type 2 diabetes [19], CVD [20], and 
even autoimmunity [21].  
 
With respect to immune system-related processes, 
previous studies have shown that both adaptive and innate 
immune responses become deregulated with aging in a 
process known as ‘immunosenescence’ [3], which is 
partially characterized by changes in the cytokine milieu 
that can lead to ‘inflammaging’ [22]. Although 
inflammation per se is an evolutionary conserved survival 
phenomenon, when it becomes chronic and systemic (i.e., 
CSI) it might contribute to many of the deleterious 
processes that occur during the aging process (e.g. 
sarcopenia, osteoporosis, type 2 diabetes, and vascular 
and neurological conditions) [2, 23]. In this regard, we 
found higher expression levels of proteins involved in the 
‘inflammaging’ process and of those involved in 
complement-mediated cytolysis, infection and auto-
immunity in the control group, whereas healthy 
centenarians had a higher expression of proteins related to 
B lymphocyte-mediated immune response and phago-
cytosis. These findings fit well with previous studies 
supporting the role of a healthy immune system as a 
differential characteristic of disease-free centenarians [23–
25]. 
 
Another major finding of our study was that healthy 
centenarians presented higher expression levels of 
proteins involved in angiogenic processes, as well as of 
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those involved in a lower incidence of CVD and 
coagulation. It has been suggested that the increased 
incidence of CVD with aging might be partly due to a 
decreased capillary density as well as to an impaired 
angiogenic response to hypoxic stimuli (i.e., reduced 
availability of endothelial nitric oxide, and decreased 
hypoxia-inducible factor 1-alpha activation and expres-
sion of angiogenic factors) [26], which would support the 
observed role of an enhanced angiogenic capacity as a 
distinguishing feature of healthy centenarians.  
 
There are some limitations to our study. Contrary to 
previous research ([see Landen et al. [27] for a review), 
we found no sex-specific differences in plasma proteins 
between centenarians and controls, which could be 
partly due to the low sample size analyzed. Our results 
– particularly at the individual protein level – should be 
replicated in larger cohorts using different metho-
dologies (e.g., enzyme-linked immunosorbent assay) 
and including individuals with different ages and health 
status. Moreover, although we highlight different 
proteins whose expression levels differed between 
healthy centenarians and controls, we cannot distinguish 
whether this was due to a genetic or an environmental 
influence. Indeed, some genetic factors are associated 
with exceptional longevity [28–30]. However, we 
consider that this might be, in turn, a strength of our 
study when compared with the analysis of other factors 
(e.g., genetics, lifestyle) alone, as it enables the 
association of both inherent and external factors 
together (reflected in the expression of a given protein) 
with exceptional, healthy longevity. It must also be 
noted that proteins were analyzed using whole-plasma 
samples, but whether their expression varies depending 
on specific cell types should be elucidated. In turn, a 
major strength of our study is the choice of a unique 
group of healthy, largely functional centenarians as a 
paradigm of healthy aging and the comparison with 
individuals showing virtually the opposite phenotype. 
On the other hand, our study has some potential  
clinical implications. First, the proteome of healthy 
centenarians remains largely unknown up to date. Thus, 
the present findings might provide preliminary data that 
could be used in future research aimed to predict at the 
proteome level the likelihood of reaching extreme 
longevity in good health conditions. In addition, since a 
‘proteomic hallmark’ of healthy centenarians was 
mainly attenuation of inflammaging and improved 
immune function, more efforts are needed in the 
promotion and implementation of lifestyle interventions 
that can reduce CSI and improve immune function in 
old people, such as regular physical exercise [31], 
tobacco smoking cessation [32], sleep improvement 
[33], body fat loss [34], healthy dietary patterns (diets 
rich in vegetables and fruits [35] or the Mediterranean 
diet, which is rich in vegetables and fruits but also in 
nuts, legumes, fish, and ‘healthy’ dietary fats) [36], and 
certain nutritional compounds, including mainly 
probiotics and omega-3 [37].  
 
In summary, we have identified a number of potential 
protein biomarkers and related molecular processes and 
pathways that differ between healthy centenarians and a 
gender-matched control group of old individuals who 
died before reaching the status of oldest old. Our results 
seem to confirm our hypothesis that centenarians have a 
healthier immune system function characterized by an 
attenuation of the “inflammaging” phenotype and a 
preserved humoral immune response. Moreover, they 
present with higher levels of proteins involved in angio-
genesis and in the reduced incidence of cardiovascular 
abnormalities, as well as of those related to an enhanced 
intercellular junction function. The proteins/pathways 
found here for healthy centenarians might provide new 
insights into the understanding of the unique biological 
characteristics that characterize these individuals, which 
might help to identify the 'proteomic profile’ associated 
with successful aging. 
 




All participants or their legal representatives provided 
written informed consent. The study was conducted in 
accordance with the Declaration of Helsinki and was 
approved by the local Institutional Review Board 
(reference #16/081). At this discovery stage, the sample 
size was determined expecting a signal of 5 standard 
deviations (SDs) and an statistical power (1- β) of 0.80 
with at least 80% of expression in the healthy 
centenarians group [39].  
 
We studied healthy centenarians (n=9 [5 female]; age 
range: 100–103 years) from the North of Italy 
(Lombardy) who were free of any clinically relevant 
condition other than the expected visual or hearing 
impairment (Table 1). Further, all of them showed a 
notably preserved ambulatory ability, with the majority 
(n=7, ~78%) showing a score of 3 in the 0 to 4 
Functional Ambulation Classification (FAC) scale [38], 
that is, they were able to walk independently with 
verbal supervision/guarding and without manual 
contact. Only two of them required light or intermittent 
manual contact during walking (FAC score of 2).  
 
Participants in the control group recruited from the 
same area (n=9 [5 female]; age range: 67 to 81 years) 
showed the opposite phenotype; that is, they all died 
before the mean expected life expectancy for Italy (~83 
years), and the great majority (n=8, ~89%) died of a 
CVD before (n=6) or shortly after (n=2) becoming an 
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octogenarian. Further, in contrast to healthy 
centenarians, they showed a remarkable functional 
impairment, with two subjects actually unable to walk 
(FAC score of 0) and two needing firm, continuous 
manual support from one person to assist balance (FAC 
score of 1). Blood sampling was performed on average 




Plasma sample preparation 
Fasting venous blood samples were collected from the 
antecubital vein in EDTA- treated vials in the morning 
after an overnight fast (08:00 to 09:00 am) and were 
kept at 4°C until preparation to prevent coagulation and 
minimize protein degradation. The specimens were then 
centrifuged at 1500 g for 10 minutes at 4°C. 
Supernatants were transferred to new tubes as aliquots. 
Ten microliters of protease inhibitor were added to each 
1.0 mL plasma aliquot, which were then stored at -80°C 
for later analysis and only one freeze-thaw cycle was 
allowed. All samples were prepared within 1 hour of 
sample collection and showed no signs of hemolysis.  
 
Protein digestion and isobaric labeling 
For the quantitative differential analysis by liquid 
chromatography coupled to tandem mass spectrometry 
(LC-MS/MS) using isobaric tags (TMT 10-plex), 100 μg 
of total protein was digested using the filter-aided protocol 
as previously described [40] with minor modifications. 
Proteins were reduced in 7 M urea and 0.1 mM Tris–HCl 
(pH 8.5) (UA) containing 5 mM TCEP (tris[2-
carboxyethyl]phosphine), and loaded onto 10 kDa 
centrifugal filter devices (NanoSep 10k Omega, Pall Life 
Sciences; Port Washington, NY). The buffer was replaced 
by washing the filters with UA, and proteins were then 
alkylated using 20 mM iodoacetamide in UA for 20 
minutes in the dark. The excess alkylating reagent was 
eliminated by washing three times with UA and three 
additional times with 50 mM ammonium bicarbonate. 
Proteins were digested overnight at 37°C with modified 
trypsin (Promega Biotech Ibérica; Alcobendas, Madrid, 
Spain) in 50 mM ammonium bicarbonate at 30:1 
protein:trypsin (w/w) ratio. The resulting peptides were 
eluted by centrifugation with 50 mM ammonium 
bicarbonate (twice) and 0.5 M sodium chloride. 
Trifluoroacetic acid was added to a final concentration of 
1% and the peptides were desalted onto C18 Oasis-HLB 
cartridges (Waters; Milford, MA) and dried-down for 
further analysis. 
 
For stable isobaric labeling, the tryptic peptides were 
dissolved in 150 mM tri-ethyl-ammonium bicarbonate 
buffer, and the peptide concentration was determined by 
measuring amide bonds with the Direct Detect system 
(Millipore, Ibérica). Equal amounts of each peptide 
sample were labeled using 10-plex TMT Reagents 
(Thermo Fisher Scientific; Waltham, MA), which were 
previously reconstituted with 70 μl of acetonitrile. After 
incubation at room temperature for 1 h, the reaction was 
stopped with 0.5% trifluoroacetic acid, incubated for 10 
minutes, and peptides were combined. Samples were 
concentrated in a Speed Vac, desalted onto C18 Oasis-
HLB cartridges and dried-down for further analysis. To 
increase proteome coverage, TMT-labeled samples 
were fractionated by high-pH reverse phase chroma-
tography (High pH Reversed-Phase Peptide 
Fractionation Kit, Pierce; Rockford, IL) and 
concentrated as before.  
 
Protein identification and quantification 
Labeled peptides were analyzed by LC-MS/MS using a 
C-18 reversed phase nano-column (75 μm I.D. × 50 cm, 
2 μm particle size, Acclaim PepMap RSLC 100 C18; 
Thermo Fisher Scientific) in a continuous acetonitrile 
gradient consisting of 0–30% B for 240 minutes and 
50–90% B for 3 minutes (A = 0.1% formic acid; B = 
95% acetonitrile, 0.1% formic acid). A flow rate of 200 
nL min-1 was used to elute peptides from the nano-
column to an emitter nanospray needle for real time 
ionization and peptide fragmentation on an Orbitrap 
Fusion mass spectrometer (Thermo Fisher Scientific). 
An enhanced FT-resolution spectrum (resolution = 
70,000 at m/z 200) followed by the MS/MS spectra 
from the Nth most intense parent ions were analyzed 
along the chromatographic run. Dynamic exclusion was 
set at 40 seconds. 
 
For peptide identification, all spectra were analyzed 
with Proteome Discoverer (version 2.1.0.81) using 
SEQUEST-HT (both from Thermo Fisher Scientific). 
For database searching at the Uniprot database 
containing all sequences from human and contaminants 
(8th November 2016; 70,902 entries), the following 
parameters were selected: trypsin digestion with two 
maximum missed cleavage sites, precursor and 
fragment mass tolerances of 2 Da and 0.02 Da, 
respectively, carbamidomethyl cysteine, and TMT 
modifications at N-terminal and Lys residues as fixed 
modifications, and methionine oxidation as dynamic 
modification. Peptide identification was performed 
using the probability ratio method [41] and false 
discovery rate (FDR) was calculated using inverted 
databases and the refined method [42] with additional 
filtering for precursor mass tolerance of 15 ppm [43].  
 
Identified peptides with an FDR equal to or lower than 
1% were used to quantify the relative abundance of 
each protein from reporter ion intensities, and statistical 
analysis of quantitative data was performed using the 
WSPP statistical model previously described [44]. In 
this model, protein log2-ratios are expressed as 
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standardized variables; that is, in units of standard 
deviation (SD) according to their estimated variances 
(Zq values).  
 
Functional protein analysis 
Functional protein analysis of the whole set of 
quantified proteins was performed using a novel 
algorithm system biology triangle, developed 
specifically for the analysis of coordinated protein 
responses in high-throughput quantitative proteomics 
experiments [45]. This algorithm correlates the 
performance of a group of proteins inside a category 
(biological process) in terms of their quantitative 
behavior (relative abundance); thus, changes can be 
detected in functional biological processes far beyond 
individual protein responses. Variations in the 
abundance of annotated functional categories were 
visualized by comparing the cumulative frequency 
(sigmoid) plots of the standardized variable with that of 
the normal distribution, as in previous research [46]. 
Individual protein changes were also considered for 





Data normality was analyzed using the Kolmogorov-
Smirnov test. Age and FAC values in the two groups 
were compared with the Mann Whitney U test. To 
identify proteins in plasma profile differentially 
expressed between healthy centenarians and controls, 
independent samples Student’s t-tests or Wilcoxon-rank 
sum tests were applied depending on data normality. 
Multi-test correction was performed according to the 
Benjamini-Hochberg method, that is, p-values were 
adjusted with FDR correction [47]. The analysis was 
repeated for the whole proteomic data and 
independently from men’s and women’s samples. 
Statistical analyses were performed with SPSS 22.0 
(IBM, Chicago, IL).  
 
Proteomics-based analysis of protein networks 
 
Processing of protein expression data 
The proteins identified in the plasma profiles were 
filtered to unique human reviewed protein entries 
according to UniProt KB [48]. To reduce a potential 
interference for high signals, the keratin protein entries 
were excluded from the analysis. Also, the protein 
entries that were traced to an unreviewed UniProt entry 
were manually curated to find a valid reviewed one. 
 
When more than one protein entry was traced to the 
same reviewed UniProt entry, the following criteria 
were applied to prevent duplications and to obtain a list 
of unique proteins: (i) to prioritize protein entries with 
an identical protein ID to the one noted in UniProt KB; 
(ii) to prioritize protein entries that were automatically 
traced to the reviewed UniProt entry over those that 
were first traced to an unreviewed or deleted one and 
then manually curated; (iii) to prioritize protein entries 
with valid signals for all the male and female samples; 
(iv) to prioritize whole protein entries over those 
referring to fragments; and (v) to apply an alphabetical 
criterion when all the criteria above did not apply.  
 
Gene set enrichment analysis 
Proteomic data were analyzed using the Gene Set 
Enrichment Analysis (GSEA) tool [49] to compare the 
differential pathways and molecular processes between 
the plasma samples of healthy centenarians and 
controls. This approach categorizes the genes according 
to a specific metric, ranking the most statistically 
significant genes at the top end of the list. The signal-to-
noise ratio for each protein was used for the ranking 
parameter analysis. A significance threshold was 
defined at FDR q-value <0.1.  
 
Specifically, as performed elsewhere [9], the 
enrichment was run over the following databases: Gene 
Ontology (GO) terms (Biological Process, Cellular 
Component, Molecular Function), Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathways, pathological 
conditions and motives included in the Biological 
Effector Database (BED) (Anaxomics proprietary 
database), PharmGKB pathways [50], the pathways 
from Small Molecule Pathway Database (SMPDB), and 
the regulatory molecular mechanisms included in 
Transcriptional Regulatory Relationships Unraveled by 
Sentence-based Text-mining (TRRUST) database. 
Entries with no signal in samples for the particular 
analysis (all samples in global analysis and sex-
exclusive for male-exclusive and female-exclusive 
analyses) were excluded from the GSEA. 
 
Visualization as a network of the relationship between 
enriched pathways  
Cytoscape 3.5.1. software was used to represent the 
relationship between the enriched pathways identified 
by GSEA (based on the number of common annotated 
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SUPPLEMENTARY MATERIALS 
 
Please browse Full Text version to see the data of Supplementary Tables 1, 2. 
 
Supplementary Table 1. List of proteins differentially expressed in healthy centenarians compared with the control 
group. 
Supplementary Table 2. Immune system-related processes differentially expressed in healthy centenarians 
compared with the control group.  
 
